Lipocalin‐2 Serum Levels in Rheumatoid Arthritis Patients Treated with Adalimumab and Its Correlation with Proinflammatory Factors
Mediators of Inflammation · 2024
DOI: 10.1155/2024/7264704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von Javier Conde-Aranda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Gastroenterology, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Adalimumab, Lipocalin-2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xunta de Galicia, Instituto de Salud Carlos III, European Social Fund.
Abstract (Originalsprache)
Background
Obesity is associated with an increased risk for different chronic diseases such as osteoarthritis (OA) or rheumatoid arthritis (RA). In fact, adipose tissue is now recognized as an endocrine organ able to secrete a wide variety of factors called adipokines, which have been demonstrated to participate in the pathophysiology of RA by regulating inflammation and immunity. LCN2 is one of these adipose tissue‐derived factors. However, scarce information is available about the levels of this adipokine in different rheumatic diseases. Therefore, we aimed to analyze LCN2 serum levels in healthy, OA, and RA patients under different treatments.
Methods
Serum levels of LCN2, among other proinflammatory and chemotactic factors, have been measured by ELISA or Multiplex in the following four groups of individuals: healthy, OA, and RA patients treated with conventional treatment or adalimumab.
Results
We found increased serum levels of LCN2 in OA and RA patients. Interestingly, LCN2 serum levels show a similar pattern to that observed for different proinflammatory and chemotactic factors, being increased in RA conventional treated patients in comparison to RA patients treated with adalimumab. Also, RA patients under conventional treatment revealed a positive and significant correlation between LCN2 and CCL2, CCL3, IL‐8, IL‐1 β , IL‐6, and CRP. In patients with RA treated with adalimumab, only IL‐6 and CRP correlated significantly with LCN2.
Conclusions
Our results clearly suggest that LCN2 is modulated and associated with inflammation in rheumatic diseases. Therefore, the serum levels of this adipokine might be used as an additional biomarker of the inflammatory/disease activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular and Cellular Gastroenterology, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
- SERGAS (Health Service from Galicia) and IDIS (Health Research Institute of Santiago de Compostela), The NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiag…
- SERGAS (Health Service from Galicia), Division of Orthopaedics Surgery and Traumatology, Santiago University Clinical Hospital, Santiago de Compostela, Spain.
- Department of Surgery and Medical-Surgery Specialities, University of Santiago de Compostela, Santiago de Compostela, Spain.
ORCID-Profile: Javier Conde-Aranda, Morena Scotece, María Varela-García, Carlos Torrijos-Pulpón, Laura Arosa, Miguel Camba-Gómez, Jesús Pino, Oreste Gualillo
Förderung
- Xunta de Galicia
- Instituto de Salud Carlos III
- European Social Fund
- European Commission
- European Regional Development Fund
Zitieren
APA
Conde-Aranda, J., Scotece, M., Varela-García, M., Torrijos-Pulpón, C., Arosa, L., Camba-Gómez, M., Pino, J., & Gualillo, O. (2024). Lipocalin‐2 Serum Levels in Rheumatoid Arthritis Patients Treated with Adalimumab and Its Correlation with Proinflammatory Factors. Mediators of Inflammation. https://doi.org/10.1155/2024/7264704
Vancouver
Conde-Aranda J, Scotece M, Varela-García M, Torrijos-Pulpón C, Arosa L, Camba-Gómez M, et al. Lipocalin‐2 Serum Levels in Rheumatoid Arthritis Patients Treated with Adalimumab and Its Correlation with Proinflammatory Factors. Mediators of Inflammation. 2024. doi:10.1155/2024/7264704
BibTeX
@article{CondeAranda2024,
author = {Conde-Aranda, Javier and Scotece, Morena and Varela-García, María and Torrijos-Pulpón, Carlos and Arosa, Laura and Camba-Gómez, Miguel and Pino, Jesús and Gualillo, Oreste},
title = {Lipocalin‐2 Serum Levels in Rheumatoid Arthritis Patients Treated with Adalimumab and Its Correlation with Proinflammatory Factors},
journal = {Mediators of Inflammation},
year = {2024},
doi = {10.1155/2024/7264704}
}
EUVIMED